Clinical Trial Update: Effects of Intravascular Administration of Mesenchymal Stromal Cells Derived from Wharton's Jelly of the Umbilical Cord on Systemic Immunomodulation and Neuroinflammation After Traumatic Brain Injury. [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial in Paris is evaluating intravenous Wharton’s jelly-derived mesenchymal stromal cells for systemic immunomodulation and neuroinflammatio…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Traumatic Brain Injury

Drugs mentioned

• Wharton’s jelly-derived mesenchymal stromal cells (Wharton’s jelly-derived mesenchymal stromal cells)

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Traumatic Brain Injury | Phase 2 | Status: RECRUITING